173 related articles for article (PubMed ID: 17518660)
1. Inhibition of histone acetylation as a tool in bone tissue engineering.
de Boer J; Licht R; Bongers M; van der Klundert T; Arends R; van Blitterswijk C
Tissue Eng; 2006 Oct; 12(10):2927-37. PubMed ID: 17518660
[TBL] [Abstract][Full Text] [Related]
2. Implantation of osteogenic differentiated donor mesenchymal stem cells causes recruitment of host cells.
Zhou Y; Fan W; Prasadam I; Crawford R; Xiao Y
J Tissue Eng Regen Med; 2015 Feb; 9(2):118-26. PubMed ID: 23038663
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast-derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation.
Man K; Brunet MY; Fernandez-Rhodes M; Williams S; Heaney LM; Gethings LA; Federici A; Davies OG; Hoey D; Cox SC
J Extracell Vesicles; 2021 Jul; 10(9):e12118. PubMed ID: 34262674
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Histone Deacetylases Enhances the Osteogenic Differentiation of Human Periodontal Ligament Cells.
Huynh NC; Everts V; Pavasant P; Ampornaramveth RS
J Cell Biochem; 2016 Jun; 117(6):1384-95. PubMed ID: 27043246
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibition enhances in-vivo bone regeneration induced by human periodontal ligament cells.
Huynh NC; Everts V; Nifuji A; Pavasant P; Ampornaramveth RS
Bone; 2017 Feb; 95():76-84. PubMed ID: 27871909
[TBL] [Abstract][Full Text] [Related]
7. Chemical and genetic blockade of HDACs enhances osteogenic differentiation of human adipose tissue-derived stem cells by oppositely affecting osteogenic and adipogenic transcription factors.
Maroni P; Brini AT; Arrigoni E; de Girolamo L; Niada S; Matteucci E; Bendinelli P; Desiderio MA
Biochem Biophys Res Commun; 2012 Nov; 428(2):271-7. PubMed ID: 23085045
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
9. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
10. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering.
Siddappa R; Licht R; van Blitterswijk C; de Boer J
J Orthop Res; 2007 Aug; 25(8):1029-41. PubMed ID: 17469183
[TBL] [Abstract][Full Text] [Related]
11. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells.
Both SK; van Apeldoorn AA; Jukes JM; Englund MC; Hyllner J; van Blitterswijk CA; de Boer J
J Tissue Eng Regen Med; 2011 Mar; 5(3):180-90. PubMed ID: 20718035
[TBL] [Abstract][Full Text] [Related]
12. Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2.
Mostafa NZ; Fitzsimmons R; Major PW; Adesida A; Jomha N; Jiang H; Uludağ H
Connect Tissue Res; 2012; 53(2):117-31. PubMed ID: 21966879
[TBL] [Abstract][Full Text] [Related]
13. An epigenetic bioactive composite scaffold with well-aligned nanofibers for functional tendon tissue engineering.
Zhang C; Wang X; Zhang E; Yang L; Yuan H; Tu W; Zhang H; Yin Z; Shen W; Chen X; Zhang Y; Ouyang H
Acta Biomater; 2018 Jan; 66():141-156. PubMed ID: 28963019
[TBL] [Abstract][Full Text] [Related]
14. Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.
Xu S; De Veirman K; Evans H; Santini GC; Vande Broek I; Leleu X; De Becker A; Van Camp B; Croucher P; Vanderkerken K; Van Riet I
Acta Pharmacol Sin; 2013 May; 34(5):699-709. PubMed ID: 23564084
[TBL] [Abstract][Full Text] [Related]
15. Effects of Tanshinone IIA on osteogenic differentiation of mouse bone marrow mesenchymal stem cells.
Qian K; Xu H; Dai T; Shi K
Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1201-9. PubMed ID: 26231349
[TBL] [Abstract][Full Text] [Related]
16. The synergistic effect of micro-topography and biochemical culture environment to promote angiogenesis and osteogenic differentiation of human mesenchymal stem cells.
Song S; Kim EJ; Bahney CS; Miclau T; Marcucio R; Roy S
Acta Biomater; 2015 May; 18():100-11. PubMed ID: 25735800
[TBL] [Abstract][Full Text] [Related]
17. Scaffold preferences of mesenchymal stromal cells and adipose-derived stem cells from green fluorescent protein transgenic mice influence the tissue engineering of bone.
Wittenburg G; Flade V; Garbe AI; Lauer G; Labudde D
Br J Oral Maxillofac Surg; 2014 May; 52(5):409-14. PubMed ID: 24685477
[TBL] [Abstract][Full Text] [Related]
18. A rapid and efficient method for expansion of human mesenchymal stem cells.
Both SK; van der Muijsenberg AJ; van Blitterswijk CA; de Boer J; de Bruijn JD
Tissue Eng; 2007 Jan; 13(1):3-9. PubMed ID: 17518576
[TBL] [Abstract][Full Text] [Related]
19. Predicting the therapeutic efficacy of MSC in bone tissue engineering using the molecular marker CADM1.
Mentink A; Hulsman M; Groen N; Licht R; Dechering KJ; van der Stok J; Alves HA; Dhert WJ; van Someren EP; Reinders MJ; van Blitterswijk CA; de Boer J
Biomaterials; 2013 Jun; 34(19):4592-601. PubMed ID: 23541110
[TBL] [Abstract][Full Text] [Related]
20. Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone.
Tu Q; Valverde P; Li S; Zhang J; Yang P; Chen J
Tissue Eng; 2007 Oct; 13(10):2431-40. PubMed ID: 17630878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
